12th International Congress on Myeloproliferative Neoplasms

 

Latest Advances in Myeloproliferative Neoplasms
19:58

12th International Congress on Myeloproliferative Neoplasms

How Should We Treat Children w/ MPN: No Guidelines on Cytoreduction or Agents Choice, Limited Data on Interferon, PEG-Int Well Tolerated w/ Stable/Improved Counts

FEATURING Nicole Kucine
  • 5 views
  • January 29, 2020
22:49

12th International Congress on Myeloproliferative Neoplasms

Old and New Myelofibrosis (MF) Classifications, When to Consider Transplantation, Results, and Current Developments

FEATURING H. Joachim Deeg
  • 27 views
  • January 20, 2020
28:48

12th International Congress on Myeloproliferative Neoplasms

Introduction to Hypoxia and Erythropoiesis in the Context of High Altitude Evolution, and Related Disorders

FEATURING Josef Prchal
  • 24 views
  • November 12, 2019
26:03

12th International Congress on Myeloproliferative Neoplasms

Moving Beyond JAKi: Ruxolitinib Failure, Newly Approved and in Development JAKi, & Novel Therapies (JAKi Combo & Novel Agents)

FEATURING Naveen Pemmaraju
  • 104 views
  • November 12, 2019
28:30

12th International Congress on Myeloproliferative Neoplasms

Is There a Role of Transplantation for CML in the Era of TKIs?

FEATURING Koen Van Besien
  • 13 views
  • November 12, 2019
16:32

12th International Congress on Myeloproliferative Neoplasms

What Are the Risk Factors for Accelerated/Blast Phase MPN and the Outcomes of Conventional Treatment Approaches?

FEATURING Olatoyosi Odenike
  • 12 views
  • November 12, 2019
08:25

12th International Congress on Myeloproliferative Neoplasms

What is the Molecular Landscape of Blast Phase MPN and the Implications for Targeted Therapeutic Approaches?

FEATURING Olatoyosi Odenike
  • 11 views
  • November 12, 2019
06:52

12th International Congress on Myeloproliferative Neoplasms

Targeting Dysregulated Iron Metabolism in Polycythemia Vera (PV) Patients to Eliminate the Need for Phlebotomy

FEATURING Ronald Hoffman
  • 10 views
  • November 25, 2019
08:25

12th International Congress on Myeloproliferative Neoplasms

Therapeutic Options for Treating MPNs are Finally Expanding: Targeting MDM2/P53

FEATURING Ronald Hoffman
  • 155 views
  • November 25, 2019
  • 1
11:27

12th International Congress on Myeloproliferative Neoplasms

Therapeutic Options for MPNs are Finally Expanding: Immunotherapies Targeting Mutant CALR in ET, Targeting TGF-B1 and NF-kB-Activation in MF

FEATURING Ronald Hoffman
  • 12 views
  • November 25, 2019
17:00

12th International Congress on Myeloproliferative Neoplasms

Interferon in Polycythemia Vera (PV) Yields Improved Myelofibrosis-Free and Overall Survival

FEATURING Richard T. Silver
  • 14 views
  • November 25, 2019
07:54

12th International Congress on Myeloproliferative Neoplasms

Update on Long Acting Interferons in MPN: Who Should Be Treated, Who Should Be Withdrawn and When to Continue With IFN Treatment?

FEATURING Heinz Gisslinger
  • 15 views
  • November 25, 2019
25:17

12th International Congress on Myeloproliferative Neoplasms

Wrangling the MPN-Related Symptom Burden: Specific Symptoms and Etiologies in Patients, Potential Suggestions on How to Work Up and Manage Troublesome Symptoms

FEATURING Robyn M. Scherber
  • 162 views
  • November 25, 2019
  • 1
26:23

12th International Congress on Myeloproliferative Neoplasms

Update on Myeloid Variant Hypereosinophilia Syndrome: Clinical Subtype is Important Predictor of Therapy Response, Targeted Therapies Changed Approach to HES

FEATURING Amy D. Klion
  • 24 views
  • November 25, 2019
  • 1
30:14

12th International Congress on Myeloproliferative Neoplasms

Tales from the Clinic on Essential Thrombocytosis: No Therapy for Asymptomatic Disease, Chemo is Toxic/Ineffective for Platelet Count Reduction, Ruxolitinib to Be Established

FEATURING Jerry L. Spivak
  • 42 views
  • November 25, 2019
13:55

12th International Congress on Myeloproliferative Neoplasms

Review of JAK2V617F and the Concept of the VAF

FEATURING Alison Moliterno
  • 12 views
  • November 25, 2019
20:40

12th International Congress on Myeloproliferative Neoplasms

Review of JAK2V617F VAF Associations in the Context of MPN and CHIP: Positive Effects on Blood Counts and Thrombosis Risk

FEATURING Alison Moliterno
  • 18 views
  • November 25, 2019